• Source: Scopus
1990 …2022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

The research in the Diamond laboratory focuses on the interface between viral pathogenesis and the host immune response. For several years, we have been primarily focused on two globally important mosquito-borne human pathogens West Nile virus and Dengue virus. Both are single-stranded positive-sense RNA viruses of the same genus (Flavivirus) that cause human disease worldwide. Recently, we have begun to study another member of the same virus family, hepatitis C, which causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Investigations with hepatitis C virus are aimed at generating a novel mouse model and understanding the epitope specificity of protective antibodies against this virus.

Clinical interests

West Nile virus, Dengue virus, Chikungunya virus, antibody immunity, interferon immunity


  • COVID-19


Dive into the research topics where Michael Diamond is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

    Cobb, R. R., Nkolola, J., Gilchuk, P., Chandrashekar, A., Yu, J., House, R. V., Earnhart, C. G., Dorsey, N. M., Hopkins, S. A., Snow, D. M., Chen, R. E., VanBlargan, L. A., Hechenblaickner, M., Hoppe, B., Collins, L., Tomic, M. T., Nonet, G. H., Hackett, K., Slaughter, J. C., Lewis, M. G. & 6 others, Andersen, H., Cook, A., Diamond, M. S., Carnahan, R. H., Barouch, D. H. & Crowe, J. E., Mar 11 2022, In: Med. 3, 3, p. 188-203.e4

    Research output: Contribution to journalArticlepeer-review

    Open Access
    2 Scopus citations
  • Advances and gaps in SARS-CoV-2 infection models

    Muñoz-Fontela, C., Widerspick, L., Albrecht, R. A., Beer, M., Carroll, M. W., de Wit, E., Diamond, M. S., Dowling, W. E., Funnell, S. G. P., García-Sastre, A., Gerhards, N. M., de Jong, R., Munster, V. J., Neyts, J., Perlman, S., Reed, D. S., Richt, J. A., Riveros-Balta, X., Roy, C. J., Salguero, F. J. & 7 others, Schotsaert, M., Schwartz, L. M., Seder, R. A., Segalés, J., Vasan, S. S., Henao-Restrepo, A. M. & Barouch, D. H., Jan 2022, In: PLoS pathogens. 18, 1, e1010161.

    Research output: Contribution to journalReview articlepeer-review

    Open Access
    3 Scopus citations
  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    VanBlargan, L. A., Errico, J. M., Halfmann, P. J., Zost, S. J., Crowe, J. E., Purcell, L. A., Kawaoka, Y., Corti, D., Fremont, D. H. & Diamond, M. S., Mar 2022, In: Nature medicine. 28, 3, p. 490-495 6 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    48 Scopus citations
  • A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    Joyce, M. G., King, H. A. D., Elakhal-Naouar, I., Ahmed, A., Peachman, K. K., Cincotta, C. M., Subra, C., Chen, R. E., Thomas, P. V., Chen, W. H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Lee, P. J., Headley, J. A., Taddese, M. G. & 38 others, Elyard, H. A., Cook, A., Anderson, A., McGuckin Wuertz, K., Dong, M., Swafford, I., Case, J. B., Currier, J. R., Lal, K. G., Molnar, S., Nair, M. S., Dussupt, V., Daye, S. P., Zeng, X., Barkei, E. K., Staples, H. M., Alfson, K., Carrion, R., Krebs, S. J., Paquin-Proulx, D., Karasavva, N., Polonis, V. R., Jagodzinski, L. L., Amare, M. F., Vasan, S., Scott, P. T., Huang, Y., Ho, D. D., de Val, N., Diamond, M. S., Lewis, M. G., Rao, M., Matyas, G. R., Gromowski, G. D., Peel, S. A., Michael, N. L., Bolton, D. L. & Modjarrad, K., Feb 16 2022, In: Science translational medicine. 14, 632, eabi5735.

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations
  • Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

    Cameroni, E., Bowen, J. E., Rosen, L. E., Saliba, C., Zepeda, S. K., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., di Iulio, J., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A. & 36 others, Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P. E., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Snell, G., Veesler, D. & Corti, D., Feb 24 2022, In: Nature. 602, 7898, p. 664-670 7 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    90 Scopus citations